Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)

NCT00131053 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Lymphoblastic Leukemia, Acute

Interventions

DRUG: Methotrexate
DRUG: Prednisolone
DRUG: Dexamethasone
DRUG: Vincristine
DRUG: Pirarubicin
DRUG: Cyclophosphamide
DRUG: L-asparaginase
DRUG: Cytarabine
DRUG: Hydrocortisone
DRUG: Mercaptopurine

Sponsor

Japan Adult Leukemia Study Group